Xiangrui Cheng

Apatinib preferentially inhibits PC9 gefitinib-resistant cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway

Yong Song, A. Olajuyin, Xiao-Ju Zhang, 2019, Cancer Cell International.

Apatinib preferentially inhibits PC9 gefitinib-resistant cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway

Yong Song, A. Olajuyin, Xiao-Ju Zhang, 2019, Cancer Cell International.

Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR

Yanfeng Gao, Jiangfeng Du, Wenjie Zhai, 2020, Cell Communication and Signaling.

Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR

Yanfeng Gao, Jiangfeng Du, Wenjie Zhai, 2020, Cell Communication and Signaling.